clarithromycin has been researched along with Enterocolitis, Pseudomembranous in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cojocariu, C; Dorobat, C; Girleanu, I; Grigore, L; Sfarti, C; Singeap, AM; Stanciu, C; Trifan, A | 1 |
| Rai, R; Rai, S | 1 |
| Ariyama, I; Furusyo, N; Hayashi, J; Kochi, S; Kubo, N; Murata, M | 1 |
| Englishby, VL | 1 |
| Booth, JC; Brown, JL; Martin, J; Teare, JP; Thomas, HC | 1 |
| Braegger, CP; Nadal, D | 1 |
| Archimandritis, A; Katsorida, M; Souyioultzis, S; Tzivras, M | 1 |
| Fung, TT; Hui, PK; Lam, KM; Lau, CF; Loo, CK; Tung, SY; Wong, AM | 1 |
| Barrett, SP; Guyot, A | 1 |
9 other study(ies) available for clarithromycin and Enterocolitis, Pseudomembranous
| Article | Year |
|---|---|
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Colonoscopy; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Pantoprazole; Proton Pump Inhibitors; Risk Factors; Treatment Outcome; Vancomycin | 2013 |
Pseudomembranous colitis requiring surgical intervention following triple therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole | 2002 |
[Pseudomembranous colitis after Helicobacter pylori eradication therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole | 2006 |
Case reports of death associated with pseudomembranous colitis and clarithromycin.
Topics: Clarithromycin; Enterocolitis, Pseudomembranous; Humans | 1995 |
Pseudomembranous colitis following clarithromycin therapy.
Topics: Aged; Clarithromycin; Duodenal Ulcer; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans | 1995 |
Clarithromycin and pseudomembranous enterocolitis.
Topics: Child, Preschool; Clarithromycin; Drug Monitoring; Enterocolitis, Pseudomembranous; Female; Humans; Otitis Media | 1994 |
Clostridium difficile colitis associated with a 'triple' regimen, containing clarithromycin and metronidazole, to eradicate Helicobacter pylori.
Topics: Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1998 |
Pseudomembranous colitis without diarrhoea following Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Occult Blood; Omeprazole; Penicillins | 2001 |
What is an appropriate control group to identify risk factors for Clostridium difficile-associated diarrhoea?
Topics: Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Research Design; Risk Factors | 2001 |